According to this study, Global Nuclear Receptor ROR-Gamma market size will reach US$ million by 2031.

Global Nuclear Receptor ROR-Gamma Market Size and Outlook 2025-31

According to this study, the global Nuclear Receptor ROR-Gamma market size will reach US$ million by 2031. United States market for Nuclear Receptor ROR-Gamma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Nuclear Receptor ROR-Gamma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Nuclear Receptor ROR-Gamma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Nuclear Receptor ROR-Gamma players cover 4SC AG, Advinus Therapeutics Ltd., Arrien Pharmaceuticals, LLC, Aurigene Discovery Technologies Limited, Biogen, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the Nuclear Receptor ROR-Gamma Industry Forecast looks at past sales and reviews total world Nuclear Receptor ROR-Gamma sales in 2024, providing a comprehensive analysis by region and market sector of projected Nuclear Receptor ROR-Gamma sales for 2025 through 2031. With Nuclear Receptor ROR-Gamma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Receptor ROR-Gamma industry. This Insight Report provides a comprehensive analysis of the global Nuclear Receptor ROR-Gamma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclear Receptor ROR-Gamma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Nuclear Receptor ROR-Gamma market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Receptor ROR-Gamma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Receptor ROR-Gamma. This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Receptor ROR-Gamma market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; VPR-66 &nbsp;&nbsp;&nbsp; INV-17 &nbsp;&nbsp;&nbsp; GSK-2981278 &nbsp;&nbsp;&nbsp; BBI-6000 &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; 4SC AG &nbsp;&nbsp;&nbsp; Advinus Therapeutics Ltd. &nbsp;&nbsp;&nbsp; Arrien Pharmaceuticals, LLC &nbsp;&nbsp;&nbsp; Aurigene Discovery Technologies Limited &nbsp;&nbsp;&nbsp; Biogen, Inc. &nbsp;&nbsp;&nbsp; Brickell Biotech, Inc. &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company &nbsp;&nbsp;&nbsp; Celgene Corporation &nbsp;&nbsp;&nbsp; Genentech, Inc. &nbsp;&nbsp;&nbsp; Genfit SA &nbsp;&nbsp;&nbsp; GlaxoSmithKline Plc &nbsp;&nbsp;&nbsp; Hanmi Pharmaceuticals, Co. Ltd. &nbsp;&nbsp;&nbsp; Karo Bio AB &nbsp;&nbsp;&nbsp; Lead Pharma Holding B.V. &nbsp;&nbsp;&nbsp; Nuevolution AB &nbsp;&nbsp;&nbsp; Phenex Pharmaceuticals AG &nbsp;&nbsp;&nbsp; Reata Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Teijin Pharma Limited &nbsp;&nbsp;&nbsp; Visionary Pharmaceuticals, Inc. &nbsp;&nbsp;&nbsp; Vitae Pharmaceuticals, Inc.

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Nuclear Receptor ROR-Gamma Market Size (2020-2031) &nbsp;2.1.2 Nuclear Receptor ROR-Gamma Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Nuclear Receptor ROR-Gamma by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Nuclear Receptor ROR-Gamma Segment by Type &nbsp;2.2.1 VPR-66 &nbsp;2.2.2 INV-17 &nbsp;2.2.3 GSK-2981278 &nbsp;2.2.4 BBI-6000 &nbsp;2.2.5 Others &nbsp;2.3 Nuclear Receptor ROR-Gamma Market Size by Type &nbsp;2.3.1 Nuclear Receptor ROR-Gamma Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Nuclear Receptor ROR-Gamma Market Size Market Share by Type (2020-2025) &nbsp;2.4 Nuclear Receptor ROR-Gamma Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.4.3 Others &nbsp;2.5 Nuclear Receptor ROR-Gamma Market Size by Application &nbsp;2.5.1 Nuclear Receptor ROR-Gamma Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Nuclear Receptor ROR-Gamma Market Size Market Share by Application (2020-2025) 3 Nuclear Receptor ROR-Gamma Market Size by Player &nbsp;3.1 Nuclear Receptor ROR-Gamma Market Size Market Share by Player &nbsp;3.1.1 Global Nuclear Receptor ROR-Gamma Revenue by Player (2020-2025) &nbsp;3.1.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Nuclear Receptor ROR-Gamma Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Nuclear Receptor ROR-Gamma by Region &nbsp;4.1 Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025) &nbsp;4.2 Global Nuclear Receptor ROR-Gamma Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025) &nbsp;4.4 APAC Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025) &nbsp;4.5 Europe Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Nuclear Receptor ROR-Gamma Market Size by Country (2020-2025) &nbsp;5.2 Americas Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) &nbsp;5.3 Americas Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Nuclear Receptor ROR-Gamma Market Size by Region (2020-2025) &nbsp;6.2 APAC Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) &nbsp;6.3 APAC Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Nuclear Receptor ROR-Gamma Market Size by Country (2020-2025) &nbsp;7.2 Europe Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) &nbsp;7.3 Europe Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Nuclear Receptor ROR-Gamma by Region (2020-2025) &nbsp;8.2 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Nuclear Receptor ROR-Gamma Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Nuclear Receptor ROR-Gamma Market Forecast &nbsp;10.1 Global Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031) &nbsp;10.1.1 Global Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Nuclear Receptor ROR-Gamma Forecast &nbsp;10.1.3 APAC Nuclear Receptor ROR-Gamma Forecast &nbsp;10.1.4 Europe Nuclear Receptor ROR-Gamma Forecast &nbsp;10.1.5 Middle East & Africa Nuclear Receptor ROR-Gamma Forecast &nbsp;10.2 Americas Nuclear Receptor ROR-Gamma Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.2.2 Canada Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.2.3 Mexico Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.2.4 Brazil Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.3 APAC Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031) &nbsp;10.3.1 China Nuclear Receptor ROR-Gamma Market Forecast &nbsp;10.3.2 Japan Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.3.3 Korea Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.3.4 Southeast Asia Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.3.5 India Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.3.6 Australia Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.4 Europe Nuclear Receptor ROR-Gamma Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.4.2 France Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.4.3 UK Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.4.4 Italy Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.4.5 Russia Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.5 Middle East & Africa Nuclear Receptor ROR-Gamma Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.5.2 South Africa Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.5.3 Israel Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.5.4 Turkey Market Nuclear Receptor ROR-Gamma Forecast &nbsp;10.6 Global Nuclear Receptor ROR-Gamma Forecast by Type (2026-2031) &nbsp;10.7 Global Nuclear Receptor ROR-Gamma Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Nuclear Receptor ROR-Gamma Forecast 11 Key Players Analysis &nbsp;11.1 4SC AG &nbsp;11.1.1 4SC AG Company Information &nbsp;11.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.1.3 4SC AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 4SC AG Main Business Overview &nbsp;11.1.5 4SC AG Latest Developments &nbsp;11.2 Advinus Therapeutics Ltd. &nbsp;11.2.1 Advinus Therapeutics Ltd. Company Information &nbsp;11.2.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.2.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Advinus Therapeutics Ltd. Main Business Overview &nbsp;11.2.5 Advinus Therapeutics Ltd. Latest Developments &nbsp;11.3 Arrien Pharmaceuticals, LLC &nbsp;11.3.1 Arrien Pharmaceuticals, LLC Company Information &nbsp;11.3.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.3.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Arrien Pharmaceuticals, LLC Main Business Overview &nbsp;11.3.5 Arrien Pharmaceuticals, LLC Latest Developments &nbsp;11.4 Aurigene Discovery Technologies Limited &nbsp;11.4.1 Aurigene Discovery Technologies Limited Company Information &nbsp;11.4.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.4.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Aurigene Discovery Technologies Limited Main Business Overview &nbsp;11.4.5 Aurigene Discovery Technologies Limited Latest Developments &nbsp;11.5 Biogen, Inc. &nbsp;11.5.1 Biogen, Inc. Company Information &nbsp;11.5.2 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.5.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Biogen, Inc. Main Business Overview &nbsp;11.5.5 Biogen, Inc. Latest Developments &nbsp;11.6 Brickell Biotech, Inc. &nbsp;11.6.1 Brickell Biotech, Inc. Company Information &nbsp;11.6.2 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.6.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Brickell Biotech, Inc. Main Business Overview &nbsp;11.6.5 Brickell Biotech, Inc. Latest Developments &nbsp;11.7 Bristol-Myers Squibb Company &nbsp;11.7.1 Bristol-Myers Squibb Company Company Information &nbsp;11.7.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.7.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Bristol-Myers Squibb Company Main Business Overview &nbsp;11.7.5 Bristol-Myers Squibb Company Latest Developments &nbsp;11.8 Celgene Corporation &nbsp;11.8.1 Celgene Corporation Company Information &nbsp;11.8.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.8.3 Celgene Corporation Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Celgene Corporation Main Business Overview &nbsp;11.8.5 Celgene Corporation Latest Developments &nbsp;11.9 Genentech, Inc. &nbsp;11.9.1 Genentech, Inc. Company Information &nbsp;11.9.2 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.9.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Genentech, Inc. Main Business Overview &nbsp;11.9.5 Genentech, Inc. Latest Developments &nbsp;11.10 Genfit SA &nbsp;11.10.1 Genfit SA Company Information &nbsp;11.10.2 Genfit SA Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.10.3 Genfit SA Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Genfit SA Main Business Overview &nbsp;11.10.5 Genfit SA Latest Developments &nbsp;11.11 GlaxoSmithKline Plc &nbsp;11.11.1 GlaxoSmithKline Plc Company Information &nbsp;11.11.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.11.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 GlaxoSmithKline Plc Main Business Overview &nbsp;11.11.5 GlaxoSmithKline Plc Latest Developments &nbsp;11.12 Hanmi Pharmaceuticals, Co. Ltd. &nbsp;11.12.1 Hanmi Pharmaceuticals, Co. Ltd. Company Information &nbsp;11.12.2 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.12.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Hanmi Pharmaceuticals, Co. Ltd. Main Business Overview &nbsp;11.12.5 Hanmi Pharmaceuticals, Co. Ltd. Latest Developments &nbsp;11.13 Karo Bio AB &nbsp;11.13.1 Karo Bio AB Company Information &nbsp;11.13.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.13.3 Karo Bio AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Karo Bio AB Main Business Overview &nbsp;11.13.5 Karo Bio AB Latest Developments &nbsp;11.14 Lead Pharma Holding B.V. &nbsp;11.14.1 Lead Pharma Holding B.V. Company Information &nbsp;11.14.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.14.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Lead Pharma Holding B.V. Main Business Overview &nbsp;11.14.5 Lead Pharma Holding B.V. Latest Developments &nbsp;11.15 Nuevolution AB &nbsp;11.15.1 Nuevolution AB Company Information &nbsp;11.15.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.15.3 Nuevolution AB Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Nuevolution AB Main Business Overview &nbsp;11.15.5 Nuevolution AB Latest Developments &nbsp;11.16 Phenex Pharmaceuticals AG &nbsp;11.16.1 Phenex Pharmaceuticals AG Company Information &nbsp;11.16.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.16.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Phenex Pharmaceuticals AG Main Business Overview &nbsp;11.16.5 Phenex Pharmaceuticals AG Latest Developments &nbsp;11.17 Reata Pharmaceuticals, Inc. &nbsp;11.17.1 Reata Pharmaceuticals, Inc. Company Information &nbsp;11.17.2 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.17.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 Reata Pharmaceuticals, Inc. Main Business Overview &nbsp;11.17.5 Reata Pharmaceuticals, Inc. Latest Developments &nbsp;11.18 Teijin Pharma Limited &nbsp;11.18.1 Teijin Pharma Limited Company Information &nbsp;11.18.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.18.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.18.4 Teijin Pharma Limited Main Business Overview &nbsp;11.18.5 Teijin Pharma Limited Latest Developments &nbsp;11.19 Visionary Pharmaceuticals, Inc. &nbsp;11.19.1 Visionary Pharmaceuticals, Inc. Company Information &nbsp;11.19.2 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.19.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.19.4 Visionary Pharmaceuticals, Inc. Main Business Overview &nbsp;11.19.5 Visionary Pharmaceuticals, Inc. Latest Developments &nbsp;11.20 Vitae Pharmaceuticals, Inc. &nbsp;11.20.1 Vitae Pharmaceuticals, Inc. Company Information &nbsp;11.20.2 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Offered &nbsp;11.20.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.20.4 Vitae Pharmaceuticals, Inc. Main Business Overview &nbsp;11.20.5 Vitae Pharmaceuticals, Inc. Latest Developments 12 Research Findings and Conclusion

Report	Global Nuclear Receptor ROR-Gamma Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI23752

Buyer Information

Order Summary